Ideas

Regenerative therapy for curing Glaucoma: Sildenafil increases the expression of genes that promote regeneration,  promotes reprogramming of aged eye cells, increases telomerase expression, increases Nmnat1 expression, increases NAD+ levels, improves neuronal dysfunction, and protects against and reverses glaucoma,  via up-regulation of its target gene, 20/January/2021, 9.29 pm

Regenerative therapy for curing Glaucoma: Sildenafil increases the expression of genes that promote regeneration,  promotes reprogramming of aged eye cells, increases telomerase expression, increases Nmnat1 expression, increases NAD+ levels, improves neuronal dysfunction, and protects against and reverses glaucoma,  via up-regulation of its target gene, 20/January/2021, 9.29 pm 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from the The Jackson Laboratory, Bar Harbor, ME 04609, USA; Department of Ophthalmology, Tufts University of Medicine, Boston, MA 02111, USA; The Howard Hughes…

read more

Regenerative cardiovascular therapy: ΔNp63α inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte proliferation, regeneration, and survival after myocardial infarction, via up-regulation of its target gene, 20/January/2021, 8.45 pm

Regenerative cardiovascular therapy: ΔNp63α inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte proliferation, regeneration, and survival after myocardial infarction, via up-regulation of its target gene, 20/January/2021, 8.45 pm 960 720 Dr Boomi's Genom-2-Discovery Center

What they say:  A recent study from the Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Frankfurt, Germany shows that “MicroRNA-34a regulates cardiac ageing and function.” This study was published, in the 7 March  2013 issue of the journal Nature,  by Profs. Stefanie Dimmeler…

read more

Regenerative cardiovascular therapy: TRIM29 (Tripartite Motif Containing 29) inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte proliferation, regeneration, and survival after myocardial infarction, via up-regulation of its target gene, 20/January/2021, 8.37 pm

Regenerative cardiovascular therapy: TRIM29 (Tripartite Motif Containing 29) inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte proliferation, regeneration, and survival after myocardial infarction, via up-regulation of its target gene, 20/January/2021, 8.37 pm 960 720 Dr Boomi's Genom-2-Discovery Center

What they say:  A recent study from the Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Frankfurt, Germany shows that “MicroRNA-34a regulates cardiac ageing and function.” This study was published, in the 7 March  2013 issue of the journal Nature,  by Profs. Stefanie Dimmeler…

read more

Sleeve gastrectomy as a regenerative cardiovascular therapy: Sleeve gastrectomy inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte proliferation, regeneration, and survival after myocardial infarction, via up-regulation of its target gene, 6/January/2021, 11.33 pm

Sleeve gastrectomy as a regenerative cardiovascular therapy: Sleeve gastrectomy inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte proliferation, regeneration, and survival after myocardial infarction, via up-regulation of its target gene, 6/January/2021, 11.33 pm 960 720 Dr Boomi's Genom-2-Discovery Center

What they say:  A recent study from the Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Frankfurt, Germany shows that “MicroRNA-34a regulates cardiac ageing and function.” This study was published, in the 7 March  2013 issue of the journal Nature,  by Profs. Stefanie Dimmeler…

read more

Regenerative cardiovascular therapy: ELK1 inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte proliferation, regeneration, and survival after myocardial infarction, via up-regulation of its target gene, 1/January/2021, 11.49 pm

Regenerative cardiovascular therapy: ELK1 inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte proliferation, regeneration, and survival after myocardial infarction, via up-regulation of its target gene, 1/January/2021, 11.49 pm 960 720 Dr Boomi's Genom-2-Discovery Center

What they say:  A recent study from the Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Frankfurt, Germany shows that “MicroRNA-34a regulates cardiac ageing and function.” This study was published, in the 7 March  2013 issue of the journal Nature,  by Profs. Stefanie Dimmeler…

read more

Repurposing the tuberculosis BCG vaccine into a Prophylactic COVID-19 vaccine: Combinatorial BCG.AstaX vaccine inhibits SARS-COV-2/1, Hepatitis-B/C, Dengue, Zika, Ebola, HIV-1, Mtb, Malaria, CMV, Influenza H1NI1, respiratory syncytial, Sindbis, and SFV viruses by increasing the Levels of NRF2, TLR2, MHCII, IL-12, STAT1/2, IRF9/3, IFITM-3/2/1, Interferon-alpha/beta/gamma/lamda, AMPs, while decreasing the expression of ACE2, Furin, SR-B1, HIF-1alpha and NRP-1 (Neuropilin) and others 23/December/2020, 12.50 pm 23/December/2020, 12.50 pm

Repurposing the tuberculosis BCG vaccine into a Prophylactic COVID-19 vaccine: Combinatorial BCG.AstaX vaccine inhibits SARS-COV-2/1, Hepatitis-B/C, Dengue, Zika, Ebola, HIV-1, Mtb, Malaria, CMV, Influenza H1NI1, respiratory syncytial, Sindbis, and SFV viruses by increasing the Levels of NRF2, TLR2, MHCII, IL-12, STAT1/2, IRF9/3, IFITM-3/2/1, Interferon-alpha/beta/gamma/lamda, AMPs, while decreasing the expression of ACE2, Furin, SR-B1, HIF-1alpha and NRP-1 (Neuropilin) and others 23/December/2020, 12.50 pm 23/December/2020, 12.50 pm 1280 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say: A study from the Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard Medical School, Charlestown, MA 02129, USA shows that “The IFITM proteins…

read more